Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 17/20 | 0.59 |
| ▸ | CTSL | P07711 | 16/20 | 0.59 |
| ▸ | CTSS | P25774 | 13/20 | 0.59 |
| ▸ | CTSB | P07858 | 7/20 | 0.57 |
| ▸ | CTSV | O60911 | 2/20 | 0.57 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.45 |
| ▸ | HSPA2 | P54652 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5096358 | 0.84 | CTSK (0.53) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL4765007 | 0.81 | CTSK (0.54) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL6629287 | 0.81 | CTSK (0.68) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL6629293 | 0.81 | CTSK (0.68) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL6629289 | 0.81 | CTSK (0.68) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7005154 | 0.78 | CTSK (0.69) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL14345781 | 0.78 | CTSK (0.69) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL5099147 | 0.76 | CTSK (0.59) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL4791980 | 0.76 | CTSK (0.59) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7488463 | 0.76 | CTSK (0.75) | CTSKCTSLCTSSCTSBCTSV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1320370-A4 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORP (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1320370-A1 | METHOD OF TREATMENT | SmithKline Beecham Corporation (US) | 2003-06-25 | — | — | EP | disclosed |
| WO-2002017924-A1 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORPORATION (GB) | 2002-03-07 | — | — | WO | disclosed |